采用数字健康对接受抗癌治疗的患者进行随访和监测：Satelia®Onco在法国对患者满意度的初步结果和使用建议

IF 3.2 3区医学 Q2 ONCOLOGY

Clinical oncology Pub Date : 2025-04-26 DOI:10.1016/j.clon.2025.103856

M. Zysman , A. Creisson , G. Ghrenassia , S. Nisse-Durgeat , A. Boyer , M. Matranga , C. Bedel , N. Pages , J. Ducray

{"title":"采用数字健康对接受抗癌治疗的患者进行随访和监测：Satelia®Onco在法国对患者满意度的初步结果和使用建议","authors":"M. Zysman , A. Creisson , G. Ghrenassia , S. Nisse-Durgeat , A. Boyer , M. Matranga , C. Bedel , N. Pages , J. Ducray","doi":"10.1016/j.clon.2025.103856","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>Telemedicine involves the use of information communication technologies and aims to support disease management, enhance treatment adherence, and improve patients’ quality of life (QoL). Despite its growing advantages, many challenges persist in its widespread adoption, which may be influenced by the health status and digital literacy of users. The objective of this study was to explore patient satisfaction with a web application used for the monitoring and follow-up of anticancer treatment.</div></div><div><h3><em>Material and methods</em></h3><div>A descriptive, multicentric, survey-based study was conducted with adult patients undergoing treatment in two oncology centres in France from October 2, 2023 to December 11, 2023. The online survey included 15 items covering the perceived usefulness, ease of use, and impact on QoL of a telemedicine solution used to monitor the side effects of anticancer treatment. Analysis was stratified by cancer type, duration of use, and age group.</div></div><div><h3><em>Results</em></h3><div>A total of 104 patients participated in the study (response rate: 33.0%). Most patients were female (64.4%), aged 46–65 years (42.3%), and were receiving treatment for lung cancer (50.0%) or breast cancer (39.4%). Remote monitoring was predominantly used for less than three months (39.4%), followed by more than six months (34.6%). Patient satisfaction and recommendation rates were high across age groups, cancer type, and durations of use (82.7%, respectively). Patients with breast cancer (82.9%) and lung cancer (82.7%) reported being absolutely satisfied. Positive feedback encompassed ease of access, comprehension of follow-up questions, and perceived usefulness. Older patients reported slightly lower scores for ease of use and improvement in QoL.</div></div><div><h3><em>Conclusion</em></h3><div>To our knowledge, these findings are among the first preliminary results concerning patient satisfaction for telemedicine use to monitor the side effects of anticancer treatment in clinical practice settings in France.</div></div>","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"43 ","pages":"Article 103856"},"PeriodicalIF":3.2000,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Employing Digital Health for the Follow-up and Monitoring of Patients Undergoing Anticancer Treatment: First Results of Satelia®Onco on Patient Satisfaction and Recommendations of Use in France\",\"authors\":\"M. Zysman , A. Creisson , G. Ghrenassia , S. Nisse-Durgeat , A. Boyer , M. Matranga , C. Bedel , N. Pages , J. Ducray\",\"doi\":\"10.1016/j.clon.2025.103856\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aims</h3><div>Telemedicine involves the use of information communication technologies and aims to support disease management, enhance treatment adherence, and improve patients’ quality of life (QoL). Despite its growing advantages, many challenges persist in its widespread adoption, which may be influenced by the health status and digital literacy of users. The objective of this study was to explore patient satisfaction with a web application used for the monitoring and follow-up of anticancer treatment.</div></div><div><h3><em>Material and methods</em></h3><div>A descriptive, multicentric, survey-based study was conducted with adult patients undergoing treatment in two oncology centres in France from October 2, 2023 to December 11, 2023. The online survey included 15 items covering the perceived usefulness, ease of use, and impact on QoL of a telemedicine solution used to monitor the side effects of anticancer treatment. Analysis was stratified by cancer type, duration of use, and age group.</div></div><div><h3><em>Results</em></h3><div>A total of 104 patients participated in the study (response rate: 33.0%). Most patients were female (64.4%), aged 46–65 years (42.3%), and were receiving treatment for lung cancer (50.0%) or breast cancer (39.4%). Remote monitoring was predominantly used for less than three months (39.4%), followed by more than six months (34.6%). Patient satisfaction and recommendation rates were high across age groups, cancer type, and durations of use (82.7%, respectively). Patients with breast cancer (82.9%) and lung cancer (82.7%) reported being absolutely satisfied. Positive feedback encompassed ease of access, comprehension of follow-up questions, and perceived usefulness. Older patients reported slightly lower scores for ease of use and improvement in QoL.</div></div><div><h3><em>Conclusion</em></h3><div>To our knowledge, these findings are among the first preliminary results concerning patient satisfaction for telemedicine use to monitor the side effects of anticancer treatment in clinical practice settings in France.</div></div>\",\"PeriodicalId\":10403,\"journal\":{\"name\":\"Clinical oncology\",\"volume\":\"43 \",\"pages\":\"Article 103856\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-04-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0936655525001116\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0936655525001116","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

aimsteledicine涉及信息通信技术的使用，旨在支持疾病管理，增强治疗依从性，改善患者的生活质量（QoL）。尽管它的优势越来越大，但在广泛采用它的过程中仍然存在许多挑战，这可能受到用户健康状况和数字素养的影响。本研究的目的是探讨患者对用于抗癌治疗监测和随访的web应用程序的满意度。材料和方法一项描述性、多中心、基于调查的研究于2023年10月2日至2023年12月11日在法国两个肿瘤中心接受治疗的成年患者进行。在线调查包括15个项目，涵盖了用于监测抗癌治疗副作用的远程医疗解决方案的感知有用性、易用性和对生活质量的影响。分析按癌症类型、使用时间和年龄组进行分层。结果共104例患者参与研究，有效率为33.0%。大多数患者为女性（64.4%），年龄在46-65岁之间（42.3%），正在接受肺癌（50.0%）或乳腺癌（39.4%）的治疗。使用远程监控的时间主要少于3个月（39.4%），其次是超过6个月（34.6%）。患者满意度和推荐率在各个年龄组、癌症类型和使用时间中都很高（分别为82.7%）。乳腺癌患者（82.9%）和肺癌患者（82.7%）表示绝对满意。积极的反馈包括访问的便利性，对后续问题的理解，以及感知到的有用性。老年患者报告的易用性和生活质量改善评分略低。据我们所知，这些发现是关于法国临床实践中使用远程医疗来监测抗癌治疗副作用的患者满意度的首批初步结果之一。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Employing Digital Health for the Follow-up and Monitoring of Patients Undergoing Anticancer Treatment: First Results of Satelia®Onco on Patient Satisfaction and Recommendations of Use in France

Aims

Telemedicine involves the use of information communication technologies and aims to support disease management, enhance treatment adherence, and improve patients’ quality of life (QoL). Despite its growing advantages, many challenges persist in its widespread adoption, which may be influenced by the health status and digital literacy of users. The objective of this study was to explore patient satisfaction with a web application used for the monitoring and follow-up of anticancer treatment.

Material and methods

A descriptive, multicentric, survey-based study was conducted with adult patients undergoing treatment in two oncology centres in France from October 2, 2023 to December 11, 2023. The online survey included 15 items covering the perceived usefulness, ease of use, and impact on QoL of a telemedicine solution used to monitor the side effects of anticancer treatment. Analysis was stratified by cancer type, duration of use, and age group.

Results

A total of 104 patients participated in the study (response rate: 33.0%). Most patients were female (64.4%), aged 46–65 years (42.3%), and were receiving treatment for lung cancer (50.0%) or breast cancer (39.4%). Remote monitoring was predominantly used for less than three months (39.4%), followed by more than six months (34.6%). Patient satisfaction and recommendation rates were high across age groups, cancer type, and durations of use (82.7%, respectively). Patients with breast cancer (82.9%) and lung cancer (82.7%) reported being absolutely satisfied. Positive feedback encompassed ease of access, comprehension of follow-up questions, and perceived usefulness. Older patients reported slightly lower scores for ease of use and improvement in QoL.

Conclusion

To our knowledge, these findings are among the first preliminary results concerning patient satisfaction for telemedicine use to monitor the side effects of anticancer treatment in clinical practice settings in France.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical oncology 医学-肿瘤学

CiteScore

5.20

自引率

8.80%

发文量

332

审稿时长

40 days

期刊介绍： Clinical Oncology is an International cancer journal covering all aspects of the clinical management of cancer patients, reflecting a multidisciplinary approach to therapy. Papers, editorials and reviews are published on all types of malignant disease embracing, pathology, diagnosis and treatment, including radiotherapy, chemotherapy, surgery, combined modality treatment and palliative care. Research and review papers covering epidemiology, radiobiology, radiation physics, tumour biology, and immunology are also published, together with letters to the editor, case reports and book reviews.